RecruitingPhase 4NCT05080569
Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment
LUMO Study: Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH
Sponsor
UMC Utrecht
Enrollment
1,008 participants
Start Date
Mar 1, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The LUMO study is a multicenter, randomized controlled trial that evaluates the effectivity of luteal phase support in MOH/IUI treatment.
Eligibility
Sex: FEMALEMin Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Placebo and a drug called Progesterone Vaginal Product for people with fertility issues, infertility unexplained, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGProgesterone Vaginal Product
3dd200mg
DRUGPlacebo
3dd1 vaginal capsule
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05080569
Related Trials
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
NCT059936891 location
Reducing Psychological Barriers to PrEP Persistence Among Pregnant and Postpartum Women in Cape Town, South Africa
NCT056249312 locations
Sleep Disordered Breathing, Endothelial Function, and Adverse Events in Pregnancy
NCT059085911 location
Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania
NCT060799181 location
Better Lifestyle Counseling for African American Women During Pregnancy
NCT052341252 locations